NASDAQ:ICCC
ImmuCell Corporation Stock News
$4.91
-0.190 (-3.73%)
At Close: Apr 30, 2024
Does ImmuCell Corporation (NASDAQ:ICCC) Have A Volatile Share Price?
02:37pm, Tuesday, 12'th Nov 2019
If you own shares in ImmuCell Corporation (NASDAQ:ICCC) then it's worth thinking about how it contributes to the...
ImmuCell Q3 EPS $(0.07) Up From $(0.17) YoY, Sales $2.97M Up From $2.154M YoY
12:00am, Monday, 11'th Nov 2019The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
11:58am, Wednesday, 09'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-week highs on Tuesday. Down In The Dumps (Biotech st
The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
11:11am, Tuesday, 08'th Oct 2019ImmuCell Announces An Agreement Covering Formulation And Aseptic Filling Of Syringes For Re-Tain
12:00am, Wednesday, 11'th Sep 2019ImmuCell Receives FDA Response To First CMC Submission for Re-Tain; Second Submission Anticipated Around Q3
12:00am, Thursday, 29'th Aug 2019ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2019 Results - Earnings Call Transcript
12:00am, Tuesday, 13'th Aug 2019ImmuCell Q2 EPS $(0.09) Up From $(0.15) YoY, Sales $2.71M Down From $3.015M YoY
12:00am, Monday, 12'th Aug 2019The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO
07:46pm, Sunday, 11'th Aug 2019
Biotech stocks came under pressure this week along with the broader market amid an earnings spate. The biggest news break was an FDA probe into data integrity issues with Novartis AG (NYSE: NVS )'s re
